News By Tag
News By Location
CHI Releases Final Agenda for Ninth Annual microRNA Conference
Find Strategies to Maximize microRNA as a Target and Tool for Therapeutic Development
Among the notable presenters are leading research and development professionals in the field (partial list):
- microRNAs in Diagnostics and Targeting Rheumatic Disease
Steffen Gay, M.D., Professor, Experimental, Rheumatology, University of Zurich
- Causes and Consequences of microRNA Dysregulation in Cancer
Carlo M. Croce, M.D., Professor and Chair, Department of Molecular Virology, Immunology and Medical Genetics; Director, Institute of Genetics, Ohio State University
- Pre-Clinical Development of a Tumor Suppressor miRNA
David Brown, Ph.D., Director, Research, Mirna Therapeutics
- microRNAs: Novel Target Class for Small Molecule Drug Discovery?
Pramod Pandey, Ph.D., Senior Research Investigator, Center for Proteomic Chemistry, Integrated Lead Discovery, Novartis Institute for Biomedical Research, Inc.
- Circulating miRNAs as Biomarkers: How Far Have We Made It?
Igor Mikaelian, M.D., D.V.M., MSc, DACVP, Research Leader, Hoffman-La Roche, Inc.
- Extracting Contextual microRNA Information for Cancer Diagnostics
Lorenzo F. Sempere, Ph.D., Research Assistant, Professor, Department of Medicine, Geisel School of Medicine at Dartmouth
Early registration discounts apply. The deadline to save is December 7, 2012.
For more information and to register, please visit http://www.healthtech.com/
For sponsorship opportunities, please contact Tim McLucas at 781-972-1342 or firstname.lastname@example.org
For more information on microRNA and related conferences, please contact Jaime Hodges, at 781-972-5429 or email@example.com
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.